Biochemical markers of cardiac dysfunction in children with obstructive sleep apnoea (OSA)
- 137 Downloads
We explored relationships between biochemical markers and cardiac responses of children with and without obstructive sleep apnoea (OSA) during exercise. We hypothesised that serum markers of sympathetic nervous system activity and low-grade inflammation would correlate with cardiac responses to exercise in children with or without OSA.
The study included 40 of 71 children with previously characterised responses to cardiopulmonary exercise testing. Measures included serum cytokine levels using a multiplex bead-based assay (interleukins IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α and IFN-γ). Serum amyloid A (SAA) was quantified by nephelometry, and metanephrine/normetanephrine levels were measured by liquid chromatography, mass-spectroscopy. Comparisons were made between children with and without OSA, and with and without obesity. Relationships between biomarkers and various cardiac parameters were explored by linear regression.
Amongst the 40 children in this study, OSA was present in 23. Compared to the 17 children without OSA, those with OSA had higher resting serum IL-6 levels compared to those without (median 3.22 pg/ml vs. 2.31, p < 0.05). Regarding correlations with cardiac function after adjusting for OSA, IL-8 negatively correlated to heart rate (HR) response following exercise (p = 0.03) and IFN-γ negatively correlated with Stroke Volume Index (SVI) (p = 0.03). Both metanephrine and normetanephrine levels positively correlated with SVI (p = 0.04, p = 0.047; respectively) and QI (p = 0.04, p = 0.04; respectively) during exercise when adjusting for OSA.
Children with OSA have raised morning levels of serum IL-6. Separately, higher levels of IFN-γ and IL-8 and lower levels of metanephrine and normetanephrine related to poorer cardiac function during exercise.
KeywordsBiochemical markers Cardiac responses Obstructive sleep apnoea Cardiopulmonary exercise testing (CPET)
Body mass index
Cardiopulmonary exercise testing
Granulocyte-macrophage colony-stimulating factor
Obstructive sleep apnoea
Cardiac Output Index
Serum amyloid A
Stroke Volume Index
Tumour necrosis factor-alpha
The authors thank the staff from the David Read Sleep Unit, Respiratory Function Unit, The Children’s Hospital Institute of Sport’s Medicine and Weight Management Service and the Immunology laboratory at The Children’s Hospital at Westmead for contributing and supporting this study. Also, we thank the children and families who agree to participate in this study.
The National Health and Medical Research Council (NHMRC) provided financial support in the form of a postgraduate scholarship for Dr. Evans. The sponsor had no role in the design or conduct of this research.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name the institution/committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 1.Parish JM, Somers VK (2004) Obstructive sleep apnea and cardiovascular disease. In: Mayo clinic proceedings. ElsevierGoogle Scholar
- 6.Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S (2008) Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 51(1):84–91CrossRefGoogle Scholar
- 14.Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134CrossRefGoogle Scholar
- 18.Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Merz CNB, Sopko G (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 109(6):726–732CrossRefGoogle Scholar
- 30.Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data (314): 1–27Google Scholar
- 32.Medicine, A.A.O.S (2007) AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, DarienGoogle Scholar
- 35.Li AM, Lam HS, Chan M, So HK, Ng SK, Chan I, Lam C, Wing YK (2008) Inflammatory cytokines and childhood obstructive sleep apnoea. Ann Acad Med Singap 37(8):649–654Google Scholar
- 37.Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F (2012) Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure. Am J Phys Heart Circ Phys 303(5):H587–H596Google Scholar
- 42.Gileles-Hillel A, Alonso-Álvarez ML, Kheirandish-Gozal L, Peris E, Cordero-Guevara JA, Terán-Santos J, Martinez MG, Jurado-Luque MJ, Corral-Peñafiel J, Duran-Cantolla J (2014) Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study. Mediat Inflamm 2014:1–9CrossRefGoogle Scholar
- 50.Franscini LC, Vazquez-Montes M, Buclin T, Perera R, Dunand M, Grouzmann E, Beck-Popovic M (2015) Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: relevance to the diagnosis of neuroblastoma. Pediatr Blood Cancer 62(4):587–593CrossRefGoogle Scholar